news
Oral Citicoline Preserves Retinal Nerve Cells in 12-Month Glaucoma Trial
Researchers tracked 80 glaucoma patients over 12 months to test whether taking 500 mg of oral citicoline twice daily protected retinal nerve fibers. While eye pressure remained unchanged, the supplement group showed stabilized microperimetric sensitivity and slowed ganglion cell loss compared to controls.
Researchers tracked 80 glaucoma patients over 12 months to test whether taking 500 mg of oral citicoline twice daily protected retinal nerve fibers. While eye pressure remained unchanged, the supplement group showed stabilized microperimetric sensitivity and slowed ganglion cell loss compared to controls.
The architecture take
I used to lump citicoline in with the generic batch of nootropics people buy on Reddit for focus. This 12-month cohort study in Frontiers in Neuroscience made me reconsider where CDP-choline actually earns its keep. Researchers followed 80 patients with progressing open-angle glaucoma, dosing half with 500 mg oral citicoline twice daily alongside their standard topical eye drops. The eye pressure itself didn't budge between groups (it stayed around 14 mm Hg). But the citicoline cohort showed stabilized macular sensitivity on microperimetry and halted ganglion cell thinning, whereas the unsupplemented group kept deteriorating. Retinal ganglion cells are central nervous system tissue. That distinction matters. Citicoline works here by feeding phosphatidylcholine directly into neuronal membranes and curbing mitochondrial breakdown under vascular stress. I spend enough time staring at screens to care about optic nerve preservation before an eye doctor forces the issue. Cellular neuroprotection is the real lever here.